Natura &Co Holding S.A.

Interim Accounting Information ("ITR") Individual and Consolidated

For the six-month periods ended June 30, 2025 and 2024 Independent Auditor's Report



Deloitte Touche Tohmatsu Av. Dr. Chucri Zaidan, 1.240 -

4º ao 12º andares - Golden Tower 04711-130 - São Paulo - SP

Brazil

Tel.: + 55 (11) 5186-1000

Fax: + 55 (11) 5181-2911

https://www.deloitte.com.br

(Convenience Translation into English from the Original Previously Issued in Portuguese) REPORT ON REVIEW OF INDIVIDUAL AND CONSOLIDATED INTERIM FINANCIAL INFORMATION

To the Shareholders and Management of Natura CCo Holding S.A.

Introduction

We have reviewed the accompanying individual and consolidated interim financial information of Natura CCo Holding S.A. ("Company"), included in the Interim Financial Information Form, for the quarter ended June 30, 2025, which comprises the balance sheet as at June 30, 2025 and the related statements of profit and loss and of comprehensive income for the three and six-month periods then ended and of changes in equity and of cash flows for the six-month period then ended, including the explanatory notes.

Management is responsible for the preparation of the individual and consolidated interim financial information in accordance with technical pronouncement CPC 21 (R1) - Interim Financial Reporting and international standard IAS 34 - Interim Financial Reporting, issued by the International Accounting Standards Board - IASB, as well as for the presentation of such information in accordance with the standards issued by the Brazilian Securities and Exchange Commission (CVM), applicable to the preparation of Interim Financial Information. Our responsibility is to express a conclusion on this interim financial information based on our review.

Scope of review

We conducted our review in accordance with Brazilian and international standards on review of interim financial information (NBC TR 2410 and ISRE 2410 - Review of Interim Financial Information Performed by the Independent Auditor of the Entity, respectively). A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the standards on auditing and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion on the individual and consolidated interim financial information

Based on our review, nothing has come to our attention that causes us to believe that the accompanying individual and consolidated interim financial information included in the Interim Financial Information referred to above was not prepared, in all material respects, in accordance with technical pronouncement CPC 21 (R1) and international standard IAS 34, applicable to the preparation of Interim Financial Information, and presented in accordance with the standards issued by the CVM.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (DTTL), its global network of member firms, and their related entities (collectively, the "Deloitte organization"). DTTL (also referred to as "Deloitte Global") and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL does not provide services to clients. Please see https://www.deloitte.com/about to learn more.

Deloitte provides leading professional services to nearly 90% of the Fortune Global 500® and thousands of private companies. Our people deliver measurable and lasting results that help reinforce public trust in capital markets and enable clients to transform and thrive. Building on its 180-year history, Deloitte spans more than 150 countries and territories. Learn how Deloitte's approximately 460,000 people worldwide make an impact that matters at https://www.deloitte.com.



Other matters

Statements of value added

The aforementioned interim financial information includes the individual and consolidated statements of value added (DVA) for the six-month period ended June 30, 2025, prepared under the responsibility of the Company's Management and disclosed as supplementary information for the purposes of international standard IAS 34.

These statements have been subject to review procedures performed in conjunction with the review of the Interim Financial Information to reach a conclusion on whether they are reconciled with the interim financial information and the accounting records, as applicable, and if their form and content are in accordance with the criteria defined in technical pronouncement CPC 09 (R1) - Statement of Value Added. Based on our review, nothing has come to our attention that causes us to believe that these statements of value added were not prepared, in all material respects, in accordance with the criteria set out in such technical pronouncement and consistently with respect to the individual and consolidated interim financial information taken as a whole.

Corresponding figures examined and reviewed by another independent auditor

The corresponding figures of the balance sheet as at December 31, 2024, presented for comparison purposes, were previously audited by other independent auditors, who issued an independent auditor's report on the financial statements, without modification, dated August 11, 2025. The corresponding figures of statements of profit and loss and of comprehensive income for the three- and six-month periods ended June 30, 2024 and of changes in equity and of cash flows, for the for the six-month period then ended, presented for comparison purposes, were reviewed by other independent auditors, who issued a report on the review of quarterly information, without modification, dated August 11, 2025.





São Paulo, August 11, 2025

DELOITTE TOUCHE TOHMATSU Vagner Ricardo Alves

Auditores Independentes Ltda. Engagement Partner

50231FTA_50183_

NATURA &CO HOLDING S.A.

STATEMENT OF FINANCIAL POSITION AS OF JUNE 30, 2025 AND DECEMBER 31, 2024

(In thousands of Brazilian reais - R$)

ASSETS

Note

Paren

June 30, 2025

t

December 31, 2024

Consol

June 30, 2025

idated

December 31, 2024

LIABILITIES AND SHAREHOLDERS' EQUITY

Note

Par

June 30, 2025

ent

December 31, 2024

Consoli

June 30, 2025

dated

December 31, 2024

CURRENT

CURRENT

Cash and cash equivalents

7

2,186

7,601

1,335,137

2,641,683

Borrowings, financing and debentures

20

-

-

88,276

55,890

Short-term investments

8

-

43,740

1,007,323

1,816,443

Lease liability

18

-

9

183,399

207,245

Trade accounts receivable

9

-

-

4,527,103

5,280,765

Trade accounts payable and reverse factoring operations

21

6,399

44,310

5,031,727

6,341,783

Trade accounts receivable - Related parties

33

158,534

274,417

-

-

Suppliers - related parties

33

441,976

227,786

-

-

Inventories

10

-

-

3,021,479

3,378,152

Dividends and interest on equity payable

24

728

1,414

728

1,414

Recoverable taxes

11

-

-

906,339

728,983

Salaries, profit sharing and social charges

33,404

54,930

650,197

1,200,874

Income tax and social contribution

36,310

50,391

234,323

305,936

Tax obligations

22

22,708

44,948

502,126

674,354

Derivative financial instruments

6

-

-

65,504

342,945

Income tax and social contribution

-

-

79,228

57,218

Other current assets

14

4,906

13,774

494,247

644,640

Derivative financial instruments

6

-

-

340,137

147,480

Provision for tax, civil and labor risks

23

-

-

11,920

19,950

Other current liabilities

24

2,092

18,318

317,142

901,281

Total current assets

201,936

389,923

11,591,455

15,139,547

507,307

391,715

7,204,880

9,607,489

Non-current assets held for sale

19

-

-

7,280,495

-

Liabilities related to non-current assets held for sale

19

-

-

4,015,550

-

Total current assets

201,936

389,923

18,871,950

15,139,547

Total current liabilities

507,307

391,715

11,220,430

9,607,489

NON-CURRENT

Accounts receivable - sale of subsidiary

6

-

-

425,055

427,753

NON-CURRENT

Borrowings, financing and debentures

20

-

-

6,270,844

6,786,795

Recoverable taxes

11

-

-

549,500

648,250

Obligations with senior quota holders in Natura Pay FIDC

37

-

-

351,763

353,489

Deferred income tax and social contribution

12

37,211

58,017

1,718,833

1,905,164

Lease liabilities

18

-

355

394,759

769,587

Judicial deposits

13

-

-

576,127

544,100

Salaries, profit sharing and social charges

1,047

3,773

22,740

118,077

Derivative financial instruments

6

-

-

86,144

46,276

Tax obligations

22

-

-

176,921

176,813

Long-term investments

8

-

-

25,285

28,692

Deferred income tax and social contribution

12

-

-

135,029

1,465,143

Other non-current assets

14

-

-

97,080

1,377,722

Income tax and social contribution

-

-

126,932

417,503

Provision for tax, civil and labor risks

23

1,192

1,154

858,303

993,366

Other non-current liabilities

24

129

258

263,894

881,927

Total non-current assets

37,211

58,017

3,478,024

4,977,957

Total non-current liabilities

2,368

5,540

8,601,185

11,962,700

TOTAL LIABILITIES

509,675

397,255

19,821,615

21,570,189

SHAREHOLDERS' EQUITY

Investments

15

15,314,218

15,893,444

-

-

Capital stock

25

12,490,035

12,484,515

12,490,035

12,484,515

Property, plant and equipment

16

-

-

2,465,904

3,898,167

Treasury shares

-

(19,991)

-

(19,991)

Intangible

17

-

-

9,364,179

12,456,185

Capital reserves

10,365,739

10,481,255

10,365,739

10,481,255

Accumulated losses

(8,572,306)

(8,616,601)

(8,572,306)

(8,616,601)

Equity appraisal adjustment

760,222

1,615,272

760,222

1,615,272

Total non-current assets

15,351,429

15,951,782

15,992,623

22,375,271

Shareholders' equity attributed to the Company's shareholders

15,043,690

15,944,450

15,043,690

15,944,450

Non-controlling interest in shareholders' equity of subsidiaries

-

-

(732)

179

Total shareholders' equity

15,043,690

15,944,450

15,042,958

15,944,629

TOTAL ASSETS

15,553,365

16,341,705

34,864,573

37,514,818

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

15,553,365

16,341,705

34,864,573

37,514,818

*The accompanying notes are an integral part of the Interim Accounting Information.

STATEMENT OF PROFIT OR LOSS

FOR THE SIX-MONTH PERIODS ENDED JUNE 30, 2025 AND 2024

Consolidated

April 01, 2025 to

June 30, 2025

April 01, 2024 to

June 30 2024

(In thousands of Brazilian reais - R$, except for earnings per share)

Parent Parent

Consolidated

Note

April 01, 2025 to

April 01, 2024 to

January 01, 2025

January 01, 2024

January 01, 2025 to

January 01, 2024 to

June 30, 2025

June 30 2024

to June 30, 2025

to June 30, 2024

June 30, 2025

June 30, 2024

NET REVENUE

27

-

-

-

-

4,150,831

5,784,019

10,830,264

10,366,818

Cost of sales

28

-

-

-

-

(1,331,463)

(1,992,258)

(3,584,803)

(3,544,714)

GROSS PROFIT

-

-

-

-

2,819,368

3,791,761

7,245,461

6,822,104

OPERATING (EXPENSES) INCOME

Selling, marketing and logistics expenses

28

-

-

-

-

(1,510,139)

(2,319,249)

(4,301,607)

(4,143,954)

Administrative, R&D, IT and project expenses

28

(83,882)

(52,423)

(103,364)

(91,473)

(550,102)

(833,950)

(1,599,613)

(1,522,128)

Impairment loss on trade receivables

9

-

-

-

-

(123,411)

(127,943)

(288,068)

(257,536)

Equity income result

15

304,867

(696,710)

165,756

(790,926)

-

-

-

-

Other operating income (expenses), net

31

(931)

4

36,462

(469)

(16,524)

(42,503)

(177,989)

4,463

OPERATING (LOSS) PROFIT BEFORE FINANCIAL RESULTS

220,054

(749,129)

98,854

(882,868)

619,192

468,116

878,184

902,949

Financial results

30

(20,899)

(8,654)

(33,903)

(3,617)

(76,876)

(390,754)

(327,812)

(475,137)

PROFIT (LOSS) BEFORE INCOME TAX AND

SOCIAL CONTRIBUTION

199,155

(757,783)

64,951

(886,485)

542,316

77,362

550,372

427,812

Income tax and social contribution

12

(4,235)

(79,164)

(20,656)

(115,872)

4,560

(950,225)

(154,943)

(1,166,184)

PROFIT (LOSS) FOR THE PERIODS FROM CONTINUING OPERATIONS

194,920

(836,947)

44,295

(1,002,357)

546,876

(872,863)

395,429

(738,372)

DISCONTINUED OPERATIONS

PROFIT (LOSS) FROM DISCONTINUED OPERATIONS

-

(21,967)

-

(791,373)

(352,045)

13,773

(352,045)

(1,055,844)

PROFIT (LOSS) FOR THE PERIODS

194,920

(858,914)

44,295

(1,793,730)

194,831

(859,090)

43,384

(1,794,216)

ATTRIBUTABLE TO

The Company´s shareholders

194,920

(858,914)

44,295

(1,793,730)

194,920

(858,914)

44,295

(1,793,730)

Non-controlling shareholders

-

-

-

-

(89)

(176)

(911)

(486)

NET INCOME (LOSS) FOR THE PERIODS PER SHARE - R$

Basic

32

0.1409

(0.6209)

0.0321

(1.2974)

0.1409

(0.6209)

0.0321

(1.2974)

Diluted

32

0.1408

(0.6209)

0.0320

(1.2974)

0.1408

(0.6209)

0.0320

(1.2974)

*The accompanying notes are an integral part of the Interim Accounting Information.

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX-MONTH PERIODS ENDED JUNE 30 2025 AND 2024

(In thousands of Brazilian reais - R$)

Parent Parent Consolidated

Consolidated

Note

April 01, 2025 to

01 April, 2024 to

January 01, 2025

January 01,

April 01, 2025

01 April, 2024

January 01,

January 01, 2024

June 30, 2025

June 30, 2024

to June 30, 2025

2024 to June

to June 30,

to June 30,

2025 to June 30,

to June 30, 2024

(LOSS) PROFIT FOR THE PERIODS

Other comprehensive income (loss) to be reclassified to income statement in subsequent periods:

194,920

(858,914)

44,295

(1,793,730)

194,831

(859,090)

43,384

(1,794,216)

Conversion of financial statements of controlled companies abroad

15

(530,578)

851,802

(960,877)

1,226,865

(530,578)

853,189

(960,877)

1,228,050

Exchange rate effect on the conversion from hyperinflationary economy

15

98,118

87,388

180,570

387,502

98,118

87,388

180,570

387,502

Earnings (losses) from cash flow hedge operations

6.1

-

-

-

-

(45,586)

31,068

(101,719)

57,029

Tax effects on earnings (losses) from cash flow hedge operations

12

-

-

-

-

10,459

(12,100)

26,976

(17,850)

Equity in earnings (losses) from cash flow hedge operations

6.1

(45,586)

31,068

(101,719)

57,029

-

-

-

-

Equity in tax effects on earnings (losses) from cash flow hedge operations

12

10,459

(12,100)

26,976

(17,850)

-

-

-

-

Other comprehensive income (loss) not reclassified for the income (loss) of the periods in subsequent periods:

Actuarial earnings (losses)

-

-

- -

-

-

- (1,892)

Tax effects on earnings (losses) from actuarial

-

-

- -

-

-

- (4,815)

Equity on actuarial earnings (losses)

-

-

- (1,892)

-

-

- -

Equivalence on the tax effects of actuarial losses

-

-

- (4,815)

-

-

- -

Comprehensive loss for the periods, net of tax effects

(272,667)

99,244

(810,755)

(146,891)

(272,756)

100,455

(811,666)

(146,192)

ATTRIBUTABLE TO

The Company´s shareholders

(272,667)

99,244

(810,755)

(146,891)

(272,667)

99,244

(810,755)

(146,891)

Noncontrolling shareholders

-

-

-

-

(89)

1,211

(911)

699

(272,667)

99,244

(810,755)

(146,891)

(272,756)

100,455

(811,666)

(146,192)

*The accompanying notes are an integral part of the Interim Accounting Information.

NATURA &CO HOLDING S.A.

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

FOR THE SIX-MONTH PERIODS ENDED JUNE 30, 2025 AND 2024

(In thousands of Brazilian reais - R$)

Note

Capital Reserves

Equity appraisal adjustment

Capital stock

Treasury shares

Share premium

Special reserve

Additional paid-in capital

Loss from transactions with non-controlling shareholders

Legal profit reserve

Retained earnings

Accumulated losses

Capital transactions

Other comprehensive income (loss)

Shareholders' equity attributed to controlling shareholders

Non-controlling shareholders

Total shareholders' equity

BALANCES AS OF DECEMBER 31, 2023

12,484,515

(164,236)

9,894,936

362,059

301,572

-

780,308

-

616,475

(1,172,390)

23,103,239

17,226

23,120,465

Loss for the period

-

-

-

-

-

-

-

(1,793,730)

-

-

(1,793,730)

(486)

(1,794,216)

Exchange rate effect on the conversion from hyperinflationary economy

-

-

-

-

-

-

-

-

-

387,502

387,502

-

387,502

Other comprehensive income (loss)

-

-

-

-

-

-

-

-

-

1,259,337

1,259,337

1,185

1,260,522

Total comprehensive income (loss) for the periods

-

-

-

-

-

-

-

(1,793,730)

-

1,646,839

(146,891)

699

(146,192)

Transactions in stock and restricted shares option plans:

Provision for stock and restricted shares option plans

-

-

-

-

15,122

-

-

-

-

-

15,122

-

15,122

Exercise of stock and restricted shares option plans

-

109,324

-

-

(118,930)

-

-

-

-

-

(9,606)

-

(9,606)

Income tax on shares option plans

-

-

-

-

26,992

-

-

-

-

-

26,992

-

26,992

Transfer of grant plans to labor obligations due to the conversion of ADRs into Phantom shares

-

-

-

-

(21,138)

-

-

-

-

-

(21,138)

-

(21,138)

Distribution of additional dividends for the 2023 financial year

-

-

-

-

-

-

(685,190)

-

-

-

(685,190)

-

(685,190)

Distribution of Interest on Equity

-

-

-

-

-

-

(44,853)

-

-

-

(44,853)

-

(44,853)

BALANCES AS OF JUNE 30, 2024

12,484,515

(54,912)

9,894,936

362,059

203,618

-

50,265

(1,793,730)

616,475

474,449

22,237,675

17,925

22,255,600

BALANCES AS OF DECEMBER 31, 2024 (originally presented)

12,484,515

(19,991)

9,894,936

362,059

224,260

-

-

(8,879,594)

616,475

988,748

15,671,408

179

15,671,587

Restatement adjustments:

Fair value adjustments in the business combination with ACL at the acquisition date

-

-

-

-

-

-

-

262,993

-

-

262,993

-

262,993

Other comprehensive income

-

-

-

-

-

-

-

-

-

10,049

10,049

-

10,049

BALANCES AS OF DECEMBER 31, 2024 (restated)

12,484,515

(19,991)

9,894,936

362,059

224,260

-

-

(8,616,601)

616,475

998,797

15,944,450

179

15,944,629

Profit for the period

-

-

-

-

-

-

-

44,295

-

-

44,295

(911)

43,384

Other comprehensive income

-

-

-

-

-

-

-

-

-

(855,050)

(855,050)

-

(855,050)

Total result for the period

-

-

-

-

-

-

-

44,295

-

(855,050)

(810,755)

(911)

(811,666)

Movement of stock option plans and restricted shares:

Provision for stock and restricted shares option plans

-

-

-

-

37,532

-

-

-

-

-

37,532

-

37,532

Exercise of stock and restricted shares option plans

-

19,991

-

-

(11,728)

-

-

-

-

-

8,263

-

8,263

Capital increase

25.1

5,520

-

-

-

-

-

-

-

-

-

5,520

-

5,520

Share buyback

25.2

-

(141,320)

-

-

-

-

-

-

-

-

(141,320)

-

(141,320)

Early cancellation of the treasury stock program

25.2

-

141,320

-

-

(141,320)

-

-

-

-

-

-

-

-

BALANCES AS OF JUNE 30, 2025

12,490,035

-

9,894,936

362,059

108,744

-

-

(8,572,306)

616,475

143,747

15,043,690

(732)

15,042,958

*The accompanying notes are an integral part of the Interim Accounting Information.

NATURA &CO HOLDING S.A.

STATEMENT OF CASH FLOWS

FOR THE SIX-MONTH PERIODS ENDED JUNE 30, 2025 AND 2024

(In thousands of Brazilian reais - R$)

Note

Parent June 30, 2025 June 30, 2024

Consolidated June 30, 2025 June 30, 2024

CASH FLOW FROM OPERATING ACTIVITIES

Loss (profit) for the periods 44,295 (1,793,730) 43,384 (1,794,216)

Adjustments to reconcile the loss for the year with the net cash (used in) generated by operating activities:

Depreciation and amortization 16, 17 and 18 172 206 429,045 445,458

Gains from interest and exchange rate variations on securities (620) (9,404) (6,356) (219,113) Losses arising from transactions with swap and forward derivatives 6 - 8,563 391,596 70,782

Increase in provision for tax, civil and labor risks 23 - - 54,025 17,990

Monetary update of judicial deposits 13 - - (19,525) (13,486)

Monetary adjustment of the provision for tax, civil and labor risks 23 38 35 21,678 27,527

Income tax and social contribution 20,656 115,872 154,943 1,156,806

Result on sale and write-off of fixed and intangible assets 16, 17 and 18 - - 35,085 15,566 Equity income result 15 (165,756) 790,926 - -

Interest and exchange rate variations on leases 18 16 50 52,267 47,320 Interest, exchange rate variation on loans, financing and debentures, net of funding costs 20 - - 281,545 224,378 Provision (reversal) for losses on property, plant and equipment, intangible assets and leases - - - (1,771) Increase (provision) for reversal of stock option grant plans (10,779) (4,253) 13,097 16,346 Expected credit losses, net of reversals 9 - - 286,503 257,388

Losses on realization of inventories, net of reversals 10 - - 111,989 118,668 Effect of hyperinflationary economy - - 21,480 387,502

Tax credits - - (61,712) -

Gain from interest and exchange rate variation on receivables from related parties 17,637 - - -Adjustment to the fair value of receivables associated with loss of control of an associated company (36,462) - - -FIDC Remuneration - - (1,726) -

Loss of profits CD Canoas - - (15,000) -

(130,803)

(891,735)

1,758,291

755,698

(INCREASE) REDUCTION IN ASSETS

Accounts receivable from customers and related parties

22,909

(204,447)

(169,776)

(1,349,672)

Stocks

-

-

(632,912)

(848,561)

Taxes to be recovered

-

52,367

(135,716)

114,239

Other assets

8,868

8,624

(198,661)

(183,452)

Subtotal

31,777

(143,456)

(1,137,065)

(2,267,446)

INCREASE (REDUCTION) IN LIABILITIES

Suppliers, reverse factoring operations and related parties

176,279

(180,635)

310,811

411,523

Salaries, profit sharing and social charges, net

(24,252)

(16,340)

(251,386)

(16,079)

Tax obligations

(8,159)

(59,326)

(55,963)

4,810

Other liabilities

(16,408)

(56,866)

(107,978)

(192,798)

Subtotal

127,460

(313,167)

(104,516)

207,456

CASH GENERATED BY (USED IN) OPERATING ACTIVITIES

28,434

(1,348,358)

516,710

(1,304,292)

OTHER CASH FLOWS FROM OPERATIONAL ACTIVITIES

Income tax and social contribution payments

-

(21,299)

(134,167)

(370,918)

Judicial deposits made, net of withdrawals

13 and 23

-

(3)

(17,895)

11,441

Payments related to tax, civil and labor proceedings

23

-

-

(78,628)

(84,731)

Payment of funds for settlement of derivative transactions

-

-

(9,313)

(120,228)

Payment of interest on leases

18

(16)

(50)

(51,661)

(46,632)

Payment of interest on loans, financing and debentures

20

-

-

(233,449)

(307,463)

Operating activities - discontinued operations

-

781,068

(1,410,431)

(360,898)

CASH GENERATED (USED) IN OPERATIONAL ACTIVITIES

28,418

(588,642)

(1,418,834)

(2,583,721)

CASH FLOW FROM INVESTMENT ACTIVITIES

Additions of fixed assets and intangible assets

-

-

(165,419)

(198,299)

Receipt from the sale of fixed and intangible assets

-

-

-

9,380

Application in securities

(136,750)

(1,392,421)

(9,697,823)

(14,966,465)

Redemption of securities

180,128

2,968,776

10,250,584

17,158,799

Redemption of interest on securities

982

12,948

44,467

176,383

Receipt of dividends from subsidiaries

15

111,799

1,333,023

-

-

Capital increase in subsidiaries

Investment activities - discontinued operations

(73,335)

-

(1,347,077)

-

-

-

-(37,678)

CASH (GENERATED BY) USED IN INVESTING ACTIVITIES

82,824

1,575,249

431,809

2,142,120

CASH FLOW FROM FINANCING ACTIVITIES

Payment of lease liabilities - principal

18

(162)

(203)

(131,648)

(109,264)

Payment of loans, financing and debentures - principal

20

-

-

-

(949,914)

Obtaining loans, financing and debentures

20

-

-

2,263

131,492

Purchase of treasury shares, net of receipt of option exercise price

(121,329)

-

(121,329)

-

Payment of dividends and interest on equity

(686)

(982,832)

(686)

(982,832)

Payment of resources for settlement of operations with financial derivatives

-

-

(17,390)

(5,200)

Capital increase

Financing activities - discontinued operations

5,520

-

-

-

5,520

-

-(79,034)

CASH GENERATED (USED) IN FINANCING ACTIVITIES

(116,657)

(983,035)

(263,270)

(1,994,752)

Effect of exchange rate variation on cash and cash equivalents

-

-

(56,251)

281,747

(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

(5,415)

3,572

(1,306,546)

(2,154,606)

Opening balance of cash and cash equivalents

7,601

1,079

2,641,683

3,750,944

Closing balance of cash and cash equivalents

2,186

4,651

1,335,137

1,596,338

(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

(5,415)

3,572

(1,306,546)

(2,154,606)

*The accompanying notes are an integral part of the Interim Accounting Information.

Other moves to reconcile profit - - (34,027) (1,447)

NATURA &CO HOLDING S.A.

STATEMENT OF VALUE ADDED

FOR THE SIX-MONTH PERIODS ENDED JUNE 30, 2025 AND 2024

(In thousands of Brazilian reais - R$)

Note

Parent June 30, 2025 June 30, 2024

Consolidated June 30, 2025 June 30, 2024

INCOME

36,462

(469)

13,673,361

13,419,123

Sale of goods, products and services

-

-

14,201,129

13,789,707

Loss due to impairment of accounts receivable from customers

9

-

-

(288,068)

(257,537)

Other operating income (expenses), net

36,462

(469)

(239,700)

(113,047)

GOODS ACQUIRED FROM THIRD PARTIES

(78,563)

(54,266)

(9,320,585)

(8,828,323)

Cost of products sold and services rendered

-

-

(5,396,474)

(5,174,380)

Materials, electricity, outsourced services and other

(78,563)

(54,266)

(3,924,111)

(3,653,943)

GROSS VALUE ADDED

(42,101)

(54,735)

4,352,776

4,590,800

RETENTIONS

(172)

(206)

(429,114)

(455,607)

Depreciation and amortization

16, 17 and 18

(172)

(206)

(429,114)

(455,607)

ADDED VALUE PRODUCED BY SOCIETY

(42,273)

(54,941)

3,923,662

4,135,193

TRANSFERRED VALUE ADDED

165,756

(758,473)

490,188

217,958

Equity in subsidiaries

15

165,756

(790,926)

-

-

Financial income

29

-

32,453

490,188

217,958

ADDED VALUE TO DISTRIBUTE

123,483

(813,414)

4,413,850

4,353,151

DISCONTINUED OPERATIONS

-

(791,373)

1,287,991

318,840

Revenues

-

-

3,466,217

3,393,464

Inputs purchased from third parties

-

-

(2,473,623)

(2,870,435)

Retentions

-

-

(242,801)

(339,396)

Added value received in transfer

-

(791,373)

538,198

135,207

TOTAL ADDED VALUE TO BE DISTRIBUTED

123,483

(1,604,787)

5,701,842

4,671,991

TOTAL DISTRIBUTION OF ADDED VALUE

123,483

(1,604,787)

5,701,842

4,671,991

PERSONNEL AND SOCIAL CHARGES

28

20,683

32,421

1,678,121

1,675,556

Direct remuneration

18,656

31,417

1,238,139

1,280,394

Benefit

825

512

282,101

276,812

FGTS

1,202

492

157,881

118,350

TAXES, FEES AND CONTRIBUTIONS

Federal

24,602

24,602

120,452

120,452

1,522,300

(455,036)

2,722,872

596,298

State

-

-

1,977,336

2,126,573

REMUNERATION OF THIRD PARTY CAPITAL

33,903

36,070

818,000

693,095

Financial expenses

29

33,903

36,070

818,000

693,095

REMUNERATION OF EQUITY

44,295

(1,002,357)

395,429

(738,372)

Loss (profit) for the periods

44,295

(1,002,357)

395,429

(738,372)

Discontinued Operations

-

(791,373)

1,287,992

318,840

Personnel and Social Charges

-

-

636,235

625,893

Taxes, Fees and Contributions

-

-

742,028

592,181

Remuneration of third-party capital

-

-

261,774

156,610

Equity remuneration

-

(791,373)

(352,045)

(1,055,844)

*The accompanying notes are an integral part of the Interim Accounting Information.

INDEX OF EXPLANATORY NOTES

  1. GENERAL INFORMATION 11

  2. MANAGEMENT STATEMENT AND BASIS OF PRESENTATION OF THE INTERIM ACCOUNTING INFORMATION 14

  3. SUMMARY OF MATERIAL ACCOUNTING POLICIES 19

  4. CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS 19

  5. BUSINESS COMBINATION 20

  6. FINANCIAL RISK MANAGEMENT 23

  7. CASH AND CASH EQUIVALENTS 27

  8. SHORT-TERM INVESTMENTS 27

  9. TRADE ACCOUNTS RECEIVABLE 28

  10. INVENTORIES 29

  11. RECOVERABLE TAXES 30

  12. INCOME TAX AND SOCIAL CONTRIBUTION 30

  13. JUDICIAL DEPOSITS 31

  14. OTHER CURRENT AND NON-CURRENT ASSETS 32

  15. INVESTMENTS 33

  16. PROPERTY, PLANT AND EQUIPMENT 35

  17. INTANGIBLE ASSETS 37

  18. RIGHT OF USE AND LEASE LIABILITIES 39

  19. NON-CURRENT ASSETS HELD FOR SALE 42

  20. BORROWING, FINANCING AND DEBENTURES 44

  21. TRADE ACCOUNTS PAYABLE AND REVERSE FACTORING OPERATIONS 45

  22. TAX LIABILITES 46

  23. PROVISION FOR TAX, CIVIL AND LABOR RISKS 47

  1. SHAREHOLDERS' EQUITY 49

  2. INFORMATION ON SEGMENTS 50

  3. REVENUE 52

  4. OPERATING EXPENSES AND COST OF SALES 52

  5. EMPLOYEE BENEFITS 53

  6. FINANCIAL RESULTS 53

  7. OTHER OPERATING INCOME (EXPENSE), NET 54

  8. EARNINGS PER SHARE 54

  9. RELATED PARTY TRANSACTIONS 55

  10. COMMITMENTS 56

  11. INSURANCE 57

  12. ADDITIONAL INFORMATION RELATING TO THE STATEMENT OF CASH FLOWS 57

  13. OBLIGATIONS TO NATURA PAY FIDC SENIOR QUOTA HOLDERS 57

  14. DISCONTINUED OPERATIONS 58

  15. SUBSEQUENT EVENTS 59

  1. ‌GENERAL INFORMATION

    Natura &Co Holding S.A. ("Natura &Co") was established on January 21, 2019 with the objective of participating in other entities, as a partner or shareholder, that develop their main activities in the cosmetics, innovations and personal hygiene sector, through the development of manufacturing, distribution and marketing of their products, headquartered in Brazil, in the city of São Paulo, State of São Paulo, at Avenida Alexandre Colares, No. 1,188, Vila Jaguará, CEP 05106-000. Natura &Co and its subsidiaries are referred to as the "Company".

    The brands under the Company's management include "Natura" and "Avon". In addition to using the retail, e-commerce, business-to-business and franchise markets as product sales channels, the Company's subsidiaries stand out for their direct sales channel, conducted mainly by consultants.

    1. Corporate reorganization through reverse incorporation

      On March 25, 2025, the Company executed the "Protocol and Justification" for the Merger of Natura &Co Holding S.A. into its subsidiary, Natura Cosméticos S.A. On April 25, 2025, an Extraordinary General Meeting of Shareholders of Natura &Co Holding S.A. was held, during which the reverse merger involving the Company and its subsidiary, Natura Cosméticos S.A., was approved.

      At the meeting held on June 23, 2025, the Boards of Directors of the Company and its subsidiary, Natura Cosméticos S.A., after the fulfillment of the conditions precedent set forth in the Merger "Protocol and Justification", approved and established July 1, 2025 as the date of consummation of the Reverse Merger, including the relevant corporate and legal registrations, within the context of a corporate reorganization between entities under common control, under the terms and conditions of the Merger Protocol and Justification, which became effective on July 1, 2025.

      Following the consummation of the transaction and the resulting dissolution of the Company having occurred after the reporting date of these interim financial statements, the event had no accounting impact for the six-month period ended June 30, 2025. Further information is disclosed in Note 39 - Subsequent Events.

      The proposed merger does not interfere with the business units' strategies. In the case of Latin America, the brand integration plan (Wave 2 of Project ELO) remains in place, with its conclusion expected in the third quarter of 2025.

    2. Classification of the indirect subsidiary Avon Cosmetics Ltda ("ACL") as a non-current asset held for sale

      On June 30, 2025, the Company assessed the sale of its indirect subsidiary ACL as highly probable. This sale is part of a single coordinated plan for the disposal of a significant line of business, represented by the Avon International operating segment and a portion of the Natura &Co Latam-operating segment (Avon entities in Central America and the Dominican Republic - CARD). The asset group comprises the ACL entities, Avon Russia, and Avon CARD, the latter two being subsidiaries of ACL, which will be divested in transactions separate from ACL.

      The aforementioned asset group (ACL) collectively met the criteria for classification as "asset held for sale" and "discontinued operations" simultaneously, in connection with

      Management's strategic plan, approved by the Company's governance bodies. Therefore, this constitutes a single coordinated plan, with different buyers whose transactions may occur in a chronologically non-sequential order.

      As part of the classification of a group of assets as held for sale, the Company measures this asset group at the lower of its carrying amount and fair value less costs to sell.

      Considering the business combination with ACL, which occurred on December 04, 2024, when the preliminary fair value measurement of the acquired assets and liabilities was performed, with the subsequent conclusion of this measurement on June 30, 2025 (as disclosed in explanatory note No. 5), the Company understands that the fair value attributed in the business combination remains substantially aligned with the carrying amount then recorded. Therefore, no indication of impairment loss was identified at the time of initial recognition of the classification of the indirect subsidiary ACL as a non-current asset held for sale (see explanatory note No. 19 - Non-current assets held for sale).

      As a result of this assessment, the accounting balances represented by ACL (including recognized intangibles and goodwill balances on net assets identified in the business combination) and its subsidiaries were classified in the consolidated statement of financial position as a non-current asset held for sale and measured based on the existing carrying amounts, which substantially approximate their respective fair values. The comparative balances in the statement of financial position as of December 31, 2024, were not reclassified and restated in accordance with applicable accounting standards. In the statements of profit or loss and cash flows, the effects associated with these operations were classified as discontinued operations for the three and six-month periods ended June 30, 2025.

      Restatement in the statements of profit or loss for the comparative three and six-month periods ended June 30, 2024, was not necessary, as ACL was reacquired by the Company on December 04, 2024, in the context of the conclusion of the Chapter 11 process. Therefore, the comparative balances as of June 30, 2024, presented in the explanatory note on Discontinued Operations, substantially correspond to the values of the former subsidiary API which was deconsolidated on August 12, 2024, due to the commencement of the Chapter 11 process (see explanatory notes No. 1.3 and No. 38).

    3. Chapter 11 process of Avon Products Inc ("API") former subsidiary in the United States

      As disclosed in the financial statements for the fiscal year ended December 31, 2024, on August 12, 2024, the Company's former non-operating subsidiary and holding company for the Avon beauty brand, API, announced that it has commenced a voluntary Chapter 11 proceeding in the U.S. Bankruptcy Court for the District of Delaware. The filing aimed to facilitate the management of pre-existing debts and liabilities. API elected to sell its assets pursuant to Section 363 of the U.S. Bankruptcy Code.

      As a result, on August 12, 2024, the Company ceased to have control over the operations of API and its subsidiaries, the date of Chapter 11 filing. Therefore, on August 12, 2024, the assets and liabilities associated with that transaction, including the goodwill balances recognized upon the acquisition of API, were derecognized from the Company's equity and financial position. The respective accounting effects associated with the loss of control over the operations of API and its subsidiaries were recognized in the interim financial information for the three- and nine-month periods ended September 30, 2024. The results of the operations of API and its subsidiaries, up to August 12, 2024, were reclassified to

      discontinued operations in the income statement for the three- and nine-month periods ended September 30, 2024.

      Consequently, the Company restated the balances of the discontinued operations of API and its subsidiaries in the income statement, statement of cash flows, statement of value added, and the notes to income for the three- and six-month periods ended June 30, 2024. Further information is disclosed in Note 2.1, "Restatement of Comparative Balances for the three- and six-month periods ended June 30, 2024".

    4. Repurchase of Avon's non-U.S. operating assets under the Chapter 11 proceedings

      As disclosed in the financial statements for the fiscal year ended December 31, 2024, on December 4, 2024, the court overseeing the Chapter 11 process approved (i) the global settlement agreement between the Company and the Avon Unsecured Creditors' Committee and (ii) the sale of Avon's assets outside the United States to the Company through a credit bid in the amount of $125 million, as mentioned in explanatory note No. 1.1 in the financial statements for the fiscal year ended December 31, 2024. This approval was formalized through the issuance of court orders recorded in the bankruptcy court docket on December 6, 2024.

      As a result of the approval and implementation of the plan, the Company reacquired Avon's operating assets outside the United States as part of the Chapter 11 process initiated by API on August 12, 2024, through its indirect subsidiary, Natura &Co UK Holding Limited ("Natura &Co UK"). The net assets acquired were determined to constitute a business combination, as disclosed in note No.5 to the financial statements for the fiscal year ended December 31, 2024.

      Under the terms of the offer to repurchase the subsidiaries, the Company agreed to disburse the full amount of the debtor-in-possession (DIP) financing, totaling $43 million, and to waive all its secured and unsecured claims against API, except for the $125 million, which was used as consideration for the purchase of operations outside the United States. The effects of the waiver of secured and unsecured claims against the Avon's debtors were included in the note on discontinued operations in the financial statements for the fiscal year ended December 31, 2024, and did not impact the results for the six-month periods ended June 30, 2025, and 2024.

      On December 31, 2024, the Company presented a preliminary measurement of the business combination effects, as disclosed in explanatory note No. 5 to the financial statements of that date. The presentation was preliminary due to the late acquisition, which occurred on December 4, 2024, and the need for timely access to relevant and appropriate evidence for the fair value measurement of the net assets acquired. The assets and liabilities in the measurement process included property, plant, and equipment, intangibles (sales representatives), right-of-use assets, inventories, lease liabilities, and deferred taxes related to the fair value of these items. As of December 31, 2024, the Company had the prerogative of a 1-year period from the acquisition date to conclude the measurement of the business combination effects, as provided by CPC 15 (R1) - Business Combinations.

      On June 30, 2025, the Company concluded the fair value measurement and allocation of the business combination and recognized the adjustments to the preliminary fair values as if the accounting for the business combination had been completed on the acquisition date, December 4, 2024, as part of the requirements of applicable IFRS and CPC Accounting Standards. This represents an update to reflect new information obtained regarding Property, Plant, and Equipment and Intangibles, as well as the impacts on Deferred Tax

      Liabilities after the publication of December 31, 2024, financial statements, and does not represent a correction of an error or a change in accounting policy.

      Consequently, the Company recognized the adjustments to the fair values of the business combination with ACL retrospectively to the business combination date. As these adjustments were made within the measurement period, the comparative balances of the Statement of Financial Position and the loss for the year ended December 31, 2024 -presented in the Statement of Changes in Equity in these interim financial information -originally disclosed in the financial statements for the year ended December 31, 2024, were restated to reflect such adjustments as if they had been recorded on the business combination date. Further information on the restatement is disclosed in explanatory note No. 2.2 - Restatement of comparative balances for the year ended December 31, 2024.

      The final effects of the fair value measurement of the net assets assumed in the business combination are disclosed in explanatory note No. 5 - Business Combination.

  2. ‌MANAGEMENT STATEMENT AND BASIS OF PRESENTATION OF THE INTERIM ACCOUNTING INFORMATION

    The Company's interim accounting information, contained in the Quarterly Information Form - ITR for the six-month period ended June 30, 2025, comprises the individual and consolidated interim accounting information, prepared in accordance with Technical Pronouncement CPC 21 (R1) - Interim Financial Statements, issued by the Accounting Pronouncements Committee ("CPC"), equivalent to "IAS 34 - Interim Financial Reporting".

    The individual and consolidated interim accounting information shows all relevant information specific to the interim accounting information, and only this information, which is consistent with that used by Management in its management.

    The individual and consolidated interim financial information were approved by the Board of Directors and authorized for issuance at a meeting held on August 07, 2025.

    The individual and consolidated interim financial information was prepared based on historical cost, except for items measured at fair value against profit or loss, which include

    (i) derivative financial instruments; (ii) contingent consideration arising from the sale of the former subsidiary The Body Shop; (iii) certain financial assets referred to in note No. 6.2; (iv) measurement of the fair value of the assets and liabilities acquired and assumed in the acquisition of Avon Cosmetics Limited ('ACL') on December 4, 2024; (v) liabilities related to cash-settled share-based payment plans ('phantom shares' of B3) that were previously backed by ADRs; and (vi) financial liabilities designated as fair value hedging.

    The individual and consolidated interim financial information are expressed in thousands of Reais ("R$"), rounded to the nearest thousand, and the disclosures of amounts in other currencies, when necessary, were also made in thousands. Items disclosed in other currencies are duly identified when applicable.

    1. Restatement of comparative balances for the three- and six-month periods ended June 30, 2024

      As mentioned in Note 1.1 to the financial statements for the fiscal year ended December 31, 2024, on August 12, 2024, the Company's former subsidiary and holding company for the Avon beauty brand, API, announced that it had initiated a voluntary Chapter 11 process. This

      event resulted in the loss of control over the operations of the former subsidiary API in the quarter ended September 30, 2024, and the subsequent allocation of the effects related to the loss of control, as well as the results earned from January 1, 2024, to August 12, 2024, to discontinued operations.

      Such reclassification to discontinued operations is performed retrospectively for prior periods, as required by applicable IFRS and CPC Accounting Standards. As a result, the interim financial information for the six-month period ended June 30, 2024, originally disclosed, was restated due to the reclassifications to discontinued operations made in the statement of income for the period, the cash flows, the statement of value added, and the corresponding explanatory notes.

      The effects on the Parent Company's income statement, in the amount of R$(19,056) for the quarter and R$(781,068) for the six-month period, were reclassified from the Equity Income line item in the Operating Loss before Financial Result group to Discontinued Operations.

      The tables below summarize the reclassification adjustments made to the consolidated income statement for the three- and six-month periods ended June 30, 2024.

      Restated June 30, 2024

      Reclassification to Discontinued Operations

      ne 30, 2024

      disclosed

      Ju

      Originally

      Consolidated (April 01, 2024 to June 30, 2024)

Gross profit

4,741,660

(949,899)

3,791,761

Operating expenses

(4,477,834)

1,154,189

(3,323,645)

Operating profit before financial result

263,826

204,290

468,116

Financial result

(135,325)

(255,429)

(390,754)

Profit (loss) before income tax and social contribution

128,501

(51,139)

77,362

Income tax and social contribution

(976,764)

26,539

(950,225)

Profit (loss) before discontinued operations

(848,263)

(24,600)

(872,863)

(Loss) / Profit from discontinued operations

(10,827)

24,600

13,773

Loss for the period

(859,090)

-

(859,090)

ATTRIBUTABLE TO:

Company Shareholders

(858,914)

-

(858,914)

Non-controlling Shareholders

(176)

-

(176)

Restated June 30, 2024

Reclassification to Discontinued Operations

Originally disclosed June 30, 2024

Consolidated (April 01, 2024 to June 30, 2024)

Gross profit

8,719,833

(1,897,729)

6,822,104

Operating expenses

(8,300,772)

2,381,617

(5,919,155)

Operating profit before financial result

419,061

483,888

902,949

Financial result

(496,540)

21,403

(475,137)

Profit (loss) before income tax and social contribution

Income tax and social contribution

(77,479)

(1,213,837)

505,291

47,653

427,812

(1,166,184)

Profit (loss) before discontinued operations

(1,291,316)

552,944

(738,372)

Loss from discontinued operations

(502,900)

(552,944)

(1,055,844)

Restated June 30, 2024

Reclassification to Discontinued Operations

Originally disclosed June 30, 2024

Consolidated (April 01, 2024 to June 30, 2024)

Loss for the period

(1,794,216)

-

(1,794,216)

ATTRIBUTABLE TO:

Company Shareholders

(1,793,730)

-

(1,793,730)

Non-controlling Shareholders

(486)

-

(486)

The reclassifications made to the consolidated statement of income for the six-month period ended June 30, 2024, described above, were also reflected in the accompanying notes to the income statement balances, presented below in this interim financial information.

The effects on the Parent Company's statement of cash flows, in the amount of R$(781,068) for the six-month period ended June 30, 2024, were reclassified from the Equity Income line to the Discontinued Operations line in the Operating Activities group.

The table below summarizes the reclassification adjustments made between the activities presented in the consolidated statement of cash flows for the six-month period ended June 30, 2024.

Restated

Reclassification

Originally disclosed

Consolidated

Operating activities

(528,820)

167,922

(360,898)

Investing activities

-

(37,678)

(37,678)

Financing activities

-

(79,034)

(79,034)

The Company voluntarily amended its accounting policy related to the presentation of discontinued operations in the Statement of Value Added (SVA). This change was motivated by the need to ensure consistency in the presentation of financial statements, considering that, although CPC 09 (R1) - Statement of Value Added does not expressly address the segregation between continuing and discontinued operations, such separation is required by CPC 31 - Non-Current Asset Held for Sale and Discontinued Operations for the Income Statement and the Statement of Cash Flows.

It is important to highlight that the amendment does not result from an error or a change in accounting estimate, but from a management decision, with the objective of aligning the SVA presentation with the structure of other financial statements, providing more relevant and comparable information to users.

The new accounting policy was applied by restating the comparative balances of the SVA, including the column that shows the proportional reclassification, by activity, of the amounts related to the former subsidiary API, from continuing operations to discontinued operations, as demonstrated in the table below.

The amendment is merely reclassification in nature, not impacting on the total distributable and distributed balances of the originally disclosed SVA, nor affecting the Company's other financial statements.

The effects on the Parent Company's statement of value added, amounting to R$(781,068) for the six-month period, were reclassified from the line of Equity income from the group of Value added received in transfer to Discontinued Operations.

The table below summarizes the reclassification adjustments made to the consolidated statement of value added for the six-month period ended June 30, 2024.

Restated

Reclassification

Originally disclosed

Consolidated

Income

16,812,587

(3,393,464)

13,419,123

Sales of goods, products, and services

17,425,301

(3,635,594)

13,789,707

Loss due to impairment of accounts receivable from customers

(373,168)

115,631

(257,537)

Other operating income (expenses), net

(239,546)

126,499

(113,047)

Goods acquired from third parties

(11,195,858)

2,367,535

(8,828,323)

Cost of goods sold, and services rendered

(6,269,440)

1,095,060

(5,174,380)

Materials, electricity, outsourced services and others

(4,881,525)

1,227,582

(3,653,943)

Loss/Recovery of assets

(44,893)

44,893

-

Gross value added

5,616,729

(1,025,929)

4,590,800

Retentions

(795,003)

339,396

(455,607)

Depreciation and amortization

(795,003)

339,396

(455,607)

Added Value Produced by Society

4,821,726

(686,533)

4,135,193

Transferred value added

353,165

(135,207)

217,958

Financial income

353,165

(135,207)

217,958

Added value to distribute

5,174,891

(821,740)

4,353,151

Discontinued operations

(502,900)

821,740

318,840

Retentions

-

3,393,464

3,393,464

Goods acquired from third parties

(502,900)

(2,367,535)

(2,870,435)

Retentions

-

(339,396)

(339,396)

Transferred value added

-

135,207

135,207

Total added value to be distributed

4,671,991

-

4,671,991

Total distribution of added value

4,671,991

-

4,671,991

Personnel and social charges

2,301,449

(625,893)

1,675,556

Direct Compensation

1,777,657

(497,263)

1,280,394

Benefits

337,435

(60,623)

276,812

FGTS

186,357

(68,007)

118,350

Taxes, fees and contributions

3,315,053

(592,181)

2,722,872

Federal

643,951

(47,653)

596,298

State

2,671,101

(544,528)

2,126,573

Remuneration of third-party capital

849,705

(156,610)

603,095

Financial expenses

849,705

(156,610)

693,095

Equity Remuneration

(1,794,216)

1,055,844

(738,372)

Losses for the period

(1,794,216)

1,055,844

(738,372)

Discontinued Operations

-

318,840

318,840

Personnel and social charges

-

625,893

625,893

Taxes, fees, and contributions

-

592,181

592,181

Third-party capital remuneration

-

156,610

156,610

Equity Remuneration

-

(1,055,844)

(1,055,844)

  1. Restatement of comparative balances for the year ended December 31, 2024 -Recognition of adjustments for the measurement period of the business combination with ACL

The amounts related to the identification of assets and liabilities associated with the acquisition, as well as the measurement of their fair values, were adjusted in these interim financial statements. Such effects were recognized as part of the business combination accounting on the acquisition date, December 04, 2024. The retrospective presentation of the adjustments made within the measurement period is required by Accounting Pronouncement CPC 15(R1) - Business Combinations (IFRS 3) and does not represent a correction of error or a change in accounting policy.

The measurement of identifiable assets and liabilities at fair values on the acquisition date is presented in explanatory note no. 5, along with the nature of the adjustments associated with the restatement.

The effects, presented in the table below, recognized during the measurement period resulted in an increase in the bargain purchase gain initially recognized on December 31, 2024, in the amount of R$286,085 (considering the exchange rate prevailing on the acquisition date, December 04, 2024). This gain, as well as the foreign subsidiary balance sheet conversion adjustments related to the adjusted assets and liabilities, and the depreciation/amortization for December 2024, were retrospectively adjusted on December 31, 2024, with a corresponding entry to Accumulated Losses and Other Comprehensive Income, in the Statement of Changes in Equity.

The total net effect on the equity position resulting from the adjustments was R$273,042, composed of: R$262,993 which comprises: i) measurement period adjustments, R$286,085, ii) depreciation and amortization for December 2024 R$(16,940) and iii) reclassifications and eliminations in consolidation R$(6,152), presented as a reduction in Accumulated Losses; and R$10,049, referring to foreign subsidiary balance sheet conversion adjustments, presented in Other Comprehensive Income, in the Statement of Comprehensive Income and in the Statement of Changes in Equity.

Originally disclosed December 31, 2024

Measurement period adjustments

Depreciation and Amortization

Reclassification and Elimination

Conversion adjustments

Restated December 31,

2024

Inventories

3,378,152

581

(581)

-

-

3,378,152

Fixed Assets

3,493,953

448,361

(8,889)

(36,993)

1,735

3,898,167

Intangible Assets

12,479,004

(43,699)

(11,551)

36,993

(4,562)

12,456,185

Right of Use

1,042,962

(1,109)

1,109

-

-

1,042,962

Other Assets

2,022,362

11,803

-

(11,803)

-

2,022,362

Total Assets

37,133,423

415,937

(19,912)

(11,803)

(2,827)

37,514,818

Accounts payable from related -

(5,778)

-

5,778

-

-

Salaries, profit sharing, and 1,318,951

12,103

-

(12,103)

-

1,318,951

Deferred income tax and social

security contributions

1,356,206

124,201

(2,971)

-

(12,293)

1,465,143

Other liabilities

1,783,208

(674)

-

674

-

1,783,208

Provision for tax, civil, and labor risks

1,013,900

-

-

-

(584)

1,013,316

Total liabilities

21,461,836

129,852

(2,971)

(5,651)

(12,877)

21,570,189

Accumulated Losses

(8,879,594)

286,085

(16,940)

(6,152)

-

(8,616,601)

Other comprehensive income adjustments

1,605,223

-

-

-

10,049

1,615,272

Total Equity

15,671,587

286,085

(16,940)

(6,152)

10,049

15,944,629

parties

social security contributions

Net effect on equity position 262,993 10,049 273,042

The impact on the Parent Company, reflected in the Balance Sheet and Income Statement for the fiscal year ended December 31, 2024, amounted to R$273,042, affecting the lines of Equity Pick-up Result and Net Loss for the year, in the Income Statement, and the Investments balance, in the Balance Sheet. The effects on the consolidated statements impacted the lines of Other Operating Income and Selling, Marketing, and Logistics Expenses, totaling R$262,993.

The restatement adjustments described above were also reflected in the explanatory notes related to the opening balances of the Investment, Property, Plant, and Equipment, Intangible Assets, Contingencies, Deferred Income Tax and Social Contribution Liabilities, and Operating Segments notes, presented sequentially in these interim financial statements.

  1. ‌SUMMARY OF MATERIAL ACCOUNTING POLICIES

    The material accounting policies applied in the preparation of this individual and consolidated interim financial information are consistent with those applied and disclosed in explanatory note No. 3 to the Company's audited individual and consolidated financial statements for the year ended December 31, 2024, issued on March 14, 2025, as well as with those applied for the comparative six-month period ended June 30, 2024, except for the standards and amendments effective January 1, 2025 and for the voluntary change in accounting policy regarding the presentation of discontinued operations in the Statement of Value Added (DVA).

    The Company also considered the requirements of Technical Guidance OCPC 10 - Carbon Credits (tCO2e), Emission Allowances, and Decarbonization Credits (CBIO), effective for periods beginning on January 1, 2025, which were considered in the preparation of this interim individual and consolidated financial information, with no effects on the respective account balances.

    This interim financial information, individual and consolidated, should be read in conjunction with the financial statements, individual and consolidated, for the year ended December 31, 2024.

  2. ‌CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS

    The areas that require a higher level of judgment and are more complex, as well as the areas in which assumptions and estimates are material to the interim accounting information, were presented in the Company's individual and consolidated financial statements for the year ended December 31, 2024, in explanatory note no. 4.

    The other estimates and assumptions used in the preparation of the individual and consolidated interim financial information for the six-month period ended June 30, 2025, did not undergo significant changes in relation to those in effect on December 31, 2024.

  3. ‌BUSINESS COMBINATION

    Acquisition of Avon ("ACL")

    As disclosed in the financial projections as of December 31, 2024, and in Note 1.4, on December 4, 2024, the Company divested Avon's operating assets outside the United States ("ACL") as part of the Chapter 11 proceedings initiated by API on August 12, 2024.

    The consideration paid for obtaining control of ACL was equivalent to the credit offering made in the amount of US$125 million (R$756,688 on the acquisition date). Acquisition costs and other costs not incurred for the purpose of acquiring control of a business were not considered part of the exclusive consideration for the transfer of control and, therefore, did not affect the consideration paid and were used to determine the effects of the business combination.

    The following table summarizes the variation between the preliminary fair value measurement disclosed in the financial projections as of December 31, 2024, and the final fair value measurement of the acquisition consideration, as well as the identifiable assets and liabilities in the acquisition data.

    The effects, presented in the following table, were recognized in the measurement period and resulted in an increase in the bargain purchase gain initially identified as of December 31, 2024, of R$286,085 (considering the exchange rate in effect on the acquisition date, December 4, 2024). This gain, as well as the adjusted assets and liabilities that generated it and the depreciation/amortization for December 2024, were adjusted retrospectively as of December 31, 2024, against Accumulated Losses in the Statement of Changes in Equity; and the balance sheet translation adjustments of a foreign subsidiary were recorded against Other Comprehensive Income, as demonstrated in Note 2.2 - Representation of comparative balances for the year ended December 31, 2024.

    The amounts of assets and liabilities indicated in the business combination listed below were also reclassified in the consolidated balance sheet as a non-current asset held for sale, in the context of the Company's assessment of the sale of the indirect subsidiary ACL as highly probable, as disclosed in Notes 1.2 and 19.

    Preliminary measurement released on

    December 4, 2024

    Measurement period adjustments

    Final measurement retrospectively recognized as of

    December 4, 2024

    Consideration transferred:

    Credit offering (US$125,000)

    756,688

    -

    756,688

    Effective settlement of pre-existing relationships

    1,225,679

    -

    1,225,679

    1,982,367

    -

    1,982,367

    Fair value of acquired assets: Cash and cash equivalents

    747,144

    -

    747,144

    Accounts receivable from customers

    548,264

    -

    548,264

    Accounts receivable from related parties

    453,500

    -

    453,500

    Inventories

    849,769

    581

    850,350

    Fixed assets (a)

    892,370

    448,361

    1,340,731

    Rights of use

    256,229

    (1,109)

    255,120

    Intangible assets (b)

    2,661,406

    (43,699)

    2,617,707

    Other assets

    2,010,963

    11,803

    2,022,766

    Fair value of assumed liabilities: Account payables

    1,324,925

    -

    1,324,925

    Accounts payable to related parties

    570,226

    (5,778)

    564,448

    Lease liabilities

    287,285

    -

    287,285

    Provisions, including restructurings

    513,921

    -

    513,921

    Salaries, profit sharing, and social security contributions

    330,050

    12,103

    342,153

    Tax obligations

    97,480

    -

    97,480

    Income tax and social security contributions

    240,387 - 240,387

    Provision for tax, civil, and labor risks

    Deferred income tax and social security

    114,110

    -

    114,110

    contributions (c)

    1,178,918

    124,201

    1,303,119

    Other liabilities

    792,517

    (674)

    791,843

    Total identifiable net assets at fair value

    2,969,826

    286,085

    3,255,911

    Gain from bargain purchase recognized in the acquisition

    987,459 286,085 1,273,544

    1. Property, plant and equipment primarily consist of properties used for manufacturing, warehousing, research and development, as well as administrative purposes. The assets were measured at fair value based on recognized valuation methodologies, taking into account the nature of the assets and the availability of market data. For each asset or asset class, the valuation methodology considered the specific characteristics in order to reflect the true assessment of the asset and its fair value, as well as valuation assumptions that reflect market conditions applicable to each jurisdiction where the assets are located and the availability of relevant data. The following valuation methods were adopted:

      Cost Method: primarily applied to buildings and improvements. This method consists of estimating the replacement cost of the assets, adjusted for accumulated depreciation (physical, functional, and economic), reflecting the current value of the asset's remaining economic benefit; and

      Market Method: used for land and, when applicable, for completed properties. This method is based on comparable transactions carried out in active markets or on estimates supported by objective evidence of prices for similar assets under market conditions.

      The fair value of property, plant and equipment includes the assets acquired and recognized by ACL prior to fair value allocation, in the amount of R$786,706, combined with the effects of the fair value allocation totaling R$554,025, resulting in a total of R$1,340,731. The fair value adjustments recognized relate to the completion of assessments based on the available evidence regarding such assets, as well as the indirect effects of the measurement of intangible assets disclosed in item (b) below.

      Preliminary Measurement Final measurement measurement on period adjustments on December 4,

      December 4, 2024 2024

      ACL Accounting Balance

      929,363

      -

      929,363

      Reclassifications

      (36,993)

      (105,664)

      (142,657)

      892,370

      105,664

      786,706

      Identified fair value adjustments: Land

      -

      295,394

      295,394

      Buildings

      -

      114,070

      114,070

      Improvements

      -

      32,551

      32,551

      Machinery and Equipment

      -

      107,450

      107,450

      Others

      -

      4,560

      4,560

      -

      554,025

      554,025

      Total 892,370

      448,361

      1,340,731

      The balances presented as reclassifications represent reclassifications between property, plant and equipment and intangible assets identified during the measurement period.

    2. The fair value of intangible assets includes the intangible assets acquired and recognized by ACL prior to fair value allocation, amounting to R$ 496,034, combined with the effects of the fair value allocation totaling R$ 2,121,673, resulting in a total of R$ 2,617,707. The fair value adjustments recognized relate to the completion of assessments based on the available evidence regarding such assets, as well as the indirect effects of the measurement of property, plant and equipment disclosed above.

      Preliminary Measurement Final measurement measurement on period adjustments on December 4,

      December 4, 2024 2024

      ACL - carrying amounts

      739,497

      -

      739,497

      Legacy Goodwill

      (386,120)

      -

      (386,120)

      Reclassifications

      36,993

      105,664

      142,657

      390,370

      105,664

      496,034

      Identified fair value adjustments: Tradename "Avon"

      1,400,358

      (8,021)

      1,392,337

      Sales processes and systems

      55,378

      373

      55,750

      Developed technology

      177,200

      1,287

      178,487

      Avon Latam intellectual property licensing agreement

      190,560 582 191,143

      Sales representatives

      447,540

      (143,584)

      303,956

      2,271,036

      (149,363)

      2,121,673

      Total

      2,661,406

      (43,699)

      2,617,707

      The balances presented as reclassifications represent reclassifications between property, plant and equipment and intangible assets identified during the measurement period.

      Adjustments to sales representatives' balances are substantially associated with the effect of recognizing the property, plant and equipment disclosed above and their impact on the measurement of intangible assets through their use as "contributory assets," which represent the required return or economic return attributable to the tangible and intangible assets used to generate future revenues.

    3. This consists of the effect of deferred tax liabilities related to the adjustments made during the measurement period, substantially represented by the recognition of fair value adjustments to property, plant and equipment and the consequential adjustments to the intangible asset balances of sales representatives.

  4. ‌FINANCIAL RISK MANAGEMENT

    The information regarding general and political considerations was presented in the Company's individual and consolidated financial statements for the year ended December 31, 2024, in explanatory note 6.1., and did not undergo any changes for the six-month period ended June 30, 2025.

    1. Market risks and hedge accounting

      The Company classifies derivative financial instruments as financial derivatives and operational derivatives. Financial derivatives include swaps or forwards used to hedge foreign exchange or interest rate risks related to loans, financing, debt securities and loans between related parties. Operational derivatives include forward contracts used to hedge foreign exchange risk from the Company's operating activities (such as import and export transactions).

      As of June 30, 2025, and December 31, 2024, derivative contracts are held directly with financial institutions and not through stock exchanges and are not subject to margin deposits to guarantee these transactions.

      Consolidated

      Fair

      value

      Fair value adjustment gain (loss)

      Description

      June 30,

      2025

      December 31, 2024

      June 30,

      2025

      December 31, 2024

      Swap contracts: (a)

      Asset portion:

      IPCA long position

      856,340

      817,529

      (69,933)

      (82,454)

      Liability portion:

      Post-fixed overnight rate for interbank deposits ("CDI"):

      Short position on CDI

      (828,539)

      (822,395)

      -

      -

      Non-deliverable forward contracts: Natura Cosméticos

      -

      (25,118)

      -

      (25,118)

      Indústria e Comércio de Cosméticos Natura

      (25,631)

      11,539

      (25,631)

      11,539

      Natura Dist. MXN (Latam)

      -

      (1,131)

      -

      (1,131)

      Avon Industrial

      (4,677)

      6,574

      (4,677)

      6,574

      ACL

      -

      3,209

      -

      (10,900)

      Avon Mexico

      3,713

      -

      (3,712)

      -

      Natura &Co Luxembourg

      (189,695)

      251,534

      17,500

      8,478

      Total derivative financial instruments, net:

      (188,489)

      241,741

      (86,453)

      (93,012)

      (a) Swap transactions consist of the exchange of liability indexers (IPCA or Pre-fixed rate) for an adjustment related to a percentage of the Interbank Deposit Certificate (CDI post-fixed) variation and/or exchange rate variation, in the case of Brazil.

      Below are the changes in net derivatives balances for the six-month period ended June 30, 2025, and for the year ended December 31, 2024:

      Consolidated

      Balance as of December 31, 2023 (51,226)

      Losses arising from swap and forward derivatives operations contracts (not

      realized) - financial result

      (70,782)

      Payment of funds by settlement with derivatives - operational activity

      120,228

      Payment of resources by settlement with derivatives - financing activity

      5,200

      Losses in cash flow hedge operations (other comprehensive income)

      57,029

      Other movements

      5,446

      Balance as of June 30, 2024

      65,895

      Balance as at December 31, 2024

      241,741

      Losses from swap and forward derivative contracts in the result (unrealized) -

      financial results

      (378,040)

      Receipt of funds from settlement with derivatives - operating activity

      9,313

      Receipt of funds from settlement with derivatives - financing activity

      17,390

      Loss on cash flow hedge operations (other comprehensive income)

      (74,743)

      Other movements

      (4,150)

      Balance as of June 30, 2025

      (188,489)

      The Company conducts the formal designation for hedge accounting of certain financial and operational derivatives described above in accordance with the Company's risk management policy. The fair value of derivatives designated for cash flow and fair value hedge accounting, as well as gains and losses for the six-month period ended June 30, 2025, are presented below (consolidated interim accounting information):

      Other comprehensive income

      Subject to hedging

      Notional currency

      Fair value

      Accumulated gains (losses)

      Gains (losses) for the six-month period

      Currency swap - US$/R$

      BRL

      -

      -

      (738)

      BRL

      (4,677)

      (4,677)

      (11,251)

      BRL

      (33,709)

      (33,709)

      (78,604)

      BRL

      (9,497)

      (19,215)

      (11,126)

      (47,883)

      (57,601)

      (101,719)

      Natura Cosméticos Currency and interest rate

      Swap and forward (Avon industrial Ltda)

      Forward (Indústria e Comércio de Cosméticos Natura Ltda)

      Currency

      Currency

      Forward (Luxemburgo) Currency Total

      The movement in hedge reserves recorded in other comprehensive income is shown below:

      Consolidated

      Balance as of December 31, 2023

      (3,880)

      Change in fair value recognized in other comprehensive income

      57,029

      Tax effects on the fair value of the hedging instrument

      (17,850)

      Cash flow hedge balance on June 30, 2024

      35,299

      Balance as at December 31, 2024

      49,165

      Change in fair value recognized in other comprehensive income

      (101,719)

      Tax effects on the fair value of the hedging instrument

      26,976

      Cash flow hedge balance on June 30, 2025

      (25,578)

    2. Fair value estimate

      The Company's financial assets and liabilities substantially comprise assets and liabilities classified at level 2 of the fair value measurement hierarchy, whose assessment is based on techniques that, in addition to the quoted prices included at level 1, use other information adopted by the direct market (such as prices) or indirectly (such as driven by prices). When measuring, the carrying value represents a reasonable approximation of the fair value, as described below:

      1. The balances of cash and cash equivalents, trade accounts receivable, accounts payable to suppliers (including supplier financing arrangements), and other current liabilities are equivalent to their carrying amounts, mainly due to the short-term maturities of these instruments;

      2. The balances of the short-term investments: a) measured at amortized cost approximate their fair values as a result of the transactions to be conducted at floating interest rates; and b) measured at fair value through profit or loss are based on the rates agreed with the financial institutions considering the agreed rates among the parties, including market information that allows for such calculation;

      3. Except for the real estate receivables certificates, which are measured at fair value due to the designation as fair value hedge accounting, the carrying amounts of borrowing, financing and debentures are measured at their amortized cost and disclosed at fair value, which does not differ materially from the carrying amounts as the agreed interest rates are consistent with current market rates; and

      4. The fair value of exchange rate derivatives (swap and forwards) is determined based on the future exchange rates at the dates of the balance sheets, with the resulting amount being discounted at present value.

      There were no transfers between the measurement levels in the fair value hierarchy during the six-month periods ended June 30, 2025, and 2024 for these assets and liabilities.

      Additionally, there were no material effects on the fair value of financial assets and liabilities for the six-month periods ended June 30, 2025 and 2024 as a result of increased price volatility in markets affected by the conflict between Russia and Ukraine, counterparty risk in financial assets, or market inactivity considered in the assessment.

      For items classified at Level 3 of the fair value measurement hierarchy, please refer to subitems (a), (b), and (c) below (except for the deferred fixed consideration, which is classified at Level 2, as described in subitem (b)):

      Dynamo Beauty Ventures Ltda Fund

      The fair value of the investment in the Dynamo Beauty Ventures Ltda. Fund ("DBV Fund"), classified at level 3 of the fair value hierarchy, is calculated based on information on the net value of the investment in the Fund calculated by the Fund manager based on valuation assumptions consistent with accounting practices adopted in Brazil and IFRS, adjusted to reflect the fair value assumptions applicable to the nature of the Company's investment. The Company's valuation takes into account unobservable inputs in the model, in order to reflect the contractual restrictions on this investment for early redemption and trading of the security in the market. The significant unobservable input used in the fair value measurements reflects a discount due to the lack of liquidity of the security, which represents the values that the Company determined that market agents would take into account for these discounts when setting the price of the investment.

      Receivables associated with the sale of former subsidiary The Body Shop

      As part of the sale agreement with the purchaser of the former subsidiary The Body Shop, a contingent consideration was agreed, stipulating additional cash payments to the subsidiary Natura Cosméticos of up to £30,000 thousand in 2025 and £60,000 thousand in 2026, if certain performance measures are achieved by The Body Shop's operation in the fiscal years 2024 and 2025.

      In April 2024, when the judicial administrator's proposals were filed, additional information was made available that prospectively affected the assessment of the fair value of the receivable.

      Based on these facts and circumstances, the Company's Management assessed that the information that supported the measurement of the fair value of these receivables on December 31, 2023 could no longer be considered reliable for purposes of determining the current fair value of the receivable, thus generating an adjustment to the fair value of the receivable in the six-month period ended on June 30, 2024, with the respective impact affecting the income statement, in the line of discontinued operations in the amount of approximately R$ 485,000 (R$ 330,000, net of income tax).

      Regarding the deferred fixed consideration, due on December 29, 2028, from the acquirer of the former subsidiary The Body Shop, the Aurelius Group, in the amount of R$425,055 (R$427,753 as of December 31, 2024), the Company did not identify any indicators that the counterparty's credit risk had increased significantly to the point of requiring the recognition of expected credit losses as of June 30, 2025, and as of December 31, 2024. These receivables related to the deferred fixed consideration have a measurement classified within level 2 of the fair value measurement hierarchy.

      Receivables associated with the indirect subsidiary ACL (Parent Company)

      As disclosed in Note 4.10 in the financial statements for the fiscal year ended December 31, 2024, the Parent Company has receivables from the subsidiary ACL, eliminated on a consolidated basis, primarily related to intercompany financing provided in 2024 and in previous periods, in the original amounts of R$235,878. Considering the deterioration of the credit risk of the subsidiary ACL, the Parent Company assessed that the credit risk increased significantly during that fiscal year and estimated the predictable cash flows for its recoverability, taking into account all the contractual terms of the financial instrument, including cash flows associated with collateral held or other credit enhancements that are an integral part of the contractual terms.

      The guarantees consist primarily of rights over the intellectual property of the Avon brand and shares of the Company, which are assessed from the perspective of revenue generation of operations within the "relief from royalty" methodology, imputing a royalty percentage on such revenues in order to compensate the brand holder for the assignment. In addition to the royalty itself (which is derived from market studies supported by external appraisers), the unobservable inputs involved include the revenue and cash flow projections approved by the appropriate governance levels of the Subsidiary and used in conducting the business, as well as the discount rate, which reflects the applicable market risks.

      As of December 31, 2024, as a result of the fair value assessment of the collateral associated with the receivables, the Parent Company recognized an amount of R$ 108,886 as an adjustment to the recoverable amount of the receivables, recorded under Other Operating Expenses in the financial statements as of December 31, 2024.

      For the six-month period ended June 30, 2025, the Company did not identify any significant increase in the credit risk of these receivables. Therefore, as of June 30, 2025, the net receivables after the allowance for losses amount to R$133,972 (R$126,992 as of December 31, 2024), as detailed in Note 33 - Related Party Transactions.

  5. ‌CASH AND CASH EQUIVALENTS

    Par

    ent

    Consol

    idated

    June 30,

    December

    June 30,

    December

    2025

    31, 2024

    2025

    31, 2024

    Cash and bank deposits

    2,186

    7,601

    659,303

    1,876,354

    Certificate of bank deposits

    -

    -

    34,913

    74,661

    Repurchase operations (a)

    -

    -

    640,921

    690,668

    2,186

    7,601

    1,335,137

    2,641,683

    With the classification of the indirect subsidiary ACL as a non-current asset held for sale, the consolidated balances as of June 30, 2025, do not include the amounts related to this transaction, which are presented as of December 31, 2024.

    a) Repurchase agreements are securities issued by banks with a commitment to repurchase the securities by the issuing banks themselves and resell them by the client, at defined rates and predetermined terms, backed by private or public securities depending on the banks' availability. They are registered with the Central Securities Custody and Financial Settlement Center ("CETIP") and are highly liquid investments with a redemption period of up to 90 days. As of June 30, 2025, repurchase agreements bear an average rate of 100.1% of the CDI (100.0% of the CDI as of December 31, 2024).

  6. ‌SECURITIES

    Parent Consolidated

    June 30, December June 30, December

    2025

    31, 2024

    2025

    31, 2024

    Exclusive Investment fund (a)

    - 43,740

    -

    -

    Mutual investment funds (b)

    - -

    95,209

    579,022

    Treasury bills (c)

    - -

    304,652

    296,993

    Government securities ("LFTs") (d)

    - -

    214,866

    419,267

    Dynamo and Amazônia Viva Funds

    - -

    25,285

    28,692

    Foreign currency investment funds (e)

    - -

    392,596

    518,111

    Restricted cash

    - -

    -

    3,050

    - 43,740

    1,032,608

    1,845,134

    Current

    - 43,740

    1,007,323

    1,816,443

    Non-current

    - -

    25,285

    28,692

    1. The Company concentrates part of its investments in an exclusive investment fund, which holds shares in the Essential Investment Fund. The values of the shares held by the Company are presented under the heading "Exclusive Investment Fund" in the parent company.

      The financial statements of the Exclusive Investment Fund, in which the group holds an exclusive interest (100% of the shares), were consolidated, except for the Instituto Natura share. The portfolio values were segregated by type of investment and classified as cash equivalents and marketable securities, based on the accounting practices adopted by the Company. For purposes of consolidated presentation, the balance of the exclusive investment funds, as well as the positions of the other subsidiaries, are presented according to the financial component.

      The balance on June 30, 2025, the Crer Para Ver line represented R$31,351 (R$81,485 on December 31, 2024) in the Exclusive Investment Fund.

    2. Mutual investment funds refer to the financial investments of some of the Company's subsidiaries, which are concentrated in the Company's entities in Argentina, Chile, Colombia, and Mexico.

    3. On June 30, 2025, financial investments in Financial Bills are remunerated at an average rate of 104.80% of the CDI (104.10 on December 31, 2024).

    4. On June 30, 2025, financial investments in Public Securities (LFT) are remunerated at an average rate of 100.50% of the CDI (91.20% of the CDI on December 31, 2024).

    5. Substantially represented by investment funds and repurchase agreements backed by US government bonds and fixed income investments in emerging markets.

    6. With the classification of the subsidiary ACL as a non-current asset held for sale, the consolidated balances as of June 30, 2025, do not include the amounts related to this transaction, which are presented as of December 31, 2024.

    The composition of the securities that make up the portfolio of the Essential Investment Fund, in which the Company holds a 100% stake, as at June 30, 2025, and December 31, 2024, was as follows:

    Consoli

    dated

    June 30,

    2025

    December 31,

    2024

    Bank deposit certificates

    26,612

    24,767

    Repurchase operations (cash and cash equivalents)

    497,033

    347,710

    Treasury bills

    304,652

    296,993

    LFTs

    185,497

    169,036

    1,013,794

    838,506

  7. ‌TRADE ACCOUNTS RECEIVABLE

    Consoli

    dated

    June 30,

    2025

    December 31,

    2024

    Trade accounts receivable

    4,904,184

    5,749,687

    (-) Expected credit losses

    (377,081)

    (468,922)

    4,527,103

    5,280,765

    With the classification of the indirect subsidiary ACL as a non-current asset held for sale, the consolidated balances as of June 30, 2025, do not include the amounts related to this transaction, which are presented as of December 31, 2024.

    The maximum exposure to credit risk on the date of the interim financial statements is the carrying amount of each maturity date range, net of the expected credit losses. The following table shows trade accounts receivable by exposure to the allowance for expected credit losses as at June 30, 2025, and December 31, 2024:

    Consolidated

    June 30, 2025

    December 31, 2024

    Trade accounts Expected credit receivable losses

    Trade accounts Expected credit receivable losses

    To mature

    4,147,248

    (89,131)

    4,802,623

    (131,071)

    Past due:

    Up to 30 days

    315,373

    (29,055)

    463,718

    (53,836)

    From 31 to 60 days

    111,796

    (38,594)

    122,955

    (51,129)

    From 61 to 90 days

    87,068

    (42,063)

    96,115

    (58,803)

    From 91 to 180 days

    242,699

    (178,238)

    235,992

    (146,459)

    Over 180 days

    -

    -

    28,284

    (27,624)

    4,904,184

    (377,081)

    5,749,687

    (468,922)

    The changes for expected credit losses for the six-month periods ended June 30, 2025, and 2024 are as follows:

    Consolidated

    Balance as of December 31, 2023

    (369,485)

    Additions, net of reversals

    (373,168)

    Write-offs (a)

    244,485

    Translation adjustment

    (30,380)

    Balance as of June 30, 2024

    (528,548)

    Balance as at December 31, 2024

    (468,922)

    Additions, net of reversals

    (310,261)

    Write-offs (a)

    297,066

    Transfer of subsidiary ACL to asset held for sale

    78,305

    Translation adjustment

    26,731

    Balance as of June 30, 2025

    (377,081)

    1. The amount of additions, net of reversals, for the period includes R$(22,553) related to the subsidiary ACL, which, as of June 30, 2025, was reclassified from operating results to discontinued operations in the statement of profit or loss. In the prior period, the amount related to the subsidiary API was R$(121,005), of which R$(92,607) refers to a provision recognized by API for receivables from the former associate The Body Shop.

    2. Refers to securities overdue for more than 180 days that are written off when the Company has no expectation of recovering accounts receivable from customers and sales from the customer portfolio.

  8. ‌INVENTORIES

    Consoli

    dated

    June 30,

    2025

    December 31,

    2024

    Finished products

    2,320,611

    2,768,584

    Raw materials and packaging

    798,022

    860,033

    Auxiliary materials

    212,781

    189,922

    Products in progress

    74,966

    50,475

    (-) Losses in carrying inventories

    (384,901)

    (490,862)

    3,021,479

    3,378,152

    The movement for losses on inventory realization for the six-month periods ended June 30, 2025, and 2024 are as follows:

    Consolidated

    Balance as of December 31, 2023

    (452,092)

    Additions, net of reversals (a)

    (139,973)

    Write-offs (c)

    158,043

    Translation adjustment

    (38,584)

    Balance as of June 30, 2024

    (472,606)

    Balance as at December 31, 2024

    (490,862)

    Additions, net of reversals (a) / (b)

    (142,545)

    Write-offs (c)

    119,244

    Transfer of subsidiary ACL to asset held for sale

    108,653

    Translation adjustment

    20,609

    Balance as of June 30, 2025

    (384,901)

    1. This refers to the recognition of the losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the policy of the Company and its subsidiaries.

    2. The amount of additions, net of reversals, for the period includes R$(30,556) related to the subsidiary ACL, which, as of June 30, 2025, was reclassified from operating results to discontinued operations in the statement of profit or loss. In the prior period, the amount related to the subsidiary API was R$(21,305).

    3. This consists of write-offs of products for which losses have already been registered, whereas the Company has no expectations of sales/recoverability.

  9. ‌RECOVERABLE TAXES

    Consolida

    ted

    June 30,

    December 31,

    2025 (d)

    2024

    ICMS on acquisition of inputs (a)

    346,500

    314,586

    Taxes on purchasing inputs abroad

    307,474

    342,333

    ICMS on acquisition of fixed assets

    25,227

    20,382

    PIS/COFINS on acquisition of inputs (b)

    632,318

    549,024

    Tax on Industrialized Products ("IPI") (c)

    105,531

    74,421

    Other

    38,789

    76,487

    1,455,839

    1,377,233

    Current

    906,339

    728,983

    Non-current

    549,500

    648,250

    1. Tax credits related to the tax on the circulation of goods, interstate and intercity transportation and communication services ("ICMS") were generated mainly by purchases whose tax rate is higher than the average sales. The Company expects to realize these credits in the normal course of operation by offsetting them against sales transactions in the domestic market.

    2. The accumulated PIS and COFINS tax credits basically arise from credits on purchases of raw materials used in production and acquisition of fixed assets, as well as credits arising from the exclusion of ICMS from the PIS/COFINS calculation basis. The realization of these credits normally occurs through offsetting with sales transactions in the domestic market.

    3. Balance will be used to offset Tax on IPI payable in future operations of the Company.

    4. With the classification of the indirect subsidiary ACL as a non-current asset held for sale, the consolidated balances as of June 30, 2025, do not include the amounts related to this transaction, which are presented as of December 31, 2024.

  10. ‌INCOME TAX AND SOCIAL CONTRIBUTION

The effective tax rate calculated by the Company for the six-month period ended June 30, 2025, was 28.15%. This percentage is based on profit before income taxes of R$550,372 and income tax expense of R$154,943. The main components that cause the effective tax rate to deviate from the nominal income tax rate of 34% are significant permanent tax benefits, such as investment grants and other incentives. Additionally, the mix of profit before tax by country, tax losses that could not benefit from the respective deferred tax, differences in nominal income tax rates of foreign subsidiaries, and various permanent tax effects in local jurisdictions that increase their respective tax obligations negatively offset the tax rate composition.

Following the reclassification of the results of the former subsidiary API to discontinued operations, the effective tax rate calculated by the Company for the six-month period ended June 30, 2024, was 272.59%. This percentage is based on profit before income taxes of R$427,812 and income tax expense of R$1,166,184. The main components that cause the effective tax rate to deviate from the nominal income tax rate of 34% are the mix of profit before tax by country, tax losses that could not be benefited by the respective deferred tax, differences in nominal income tax rates of foreign subsidiaries, and various permanent tax effects in local jurisdictions that increase their respective tax obligations, including withholding taxes arising from intercompany transactions that could not be benefited. Otherwise, important permanent tax benefits, such as investment grants and other incentives, positively contribute to reductions in tax obligations and in the composition of the rate.

Attachments

  • Original document
  • Permalink

Disclaimer

Natura & Co Holding SA published this content on August 11, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 11, 2025 at 23:26 UTC.